Barely Significant
← all excerpts

The effect of transdermal estradiol or oral conjugated oestrogen and fenretinide versus placebo on haemostasis and cardiovascular risk biomarkers in a randomized breast cancer chemoprevention trial.

Ecancermedicalscience · 2008 · PMC3234057 · PMID 22275964

Europe PMCDOI
2
hedged sentences
0.0550
closest p · 1.1× alpha
0.0550
boldest claim

The sentences

borderline significantp = 0.055so close (0.05 < p ≤ 0.1)
Antithrombin-III showed a 4% borderline significant reduction in the fenretinide arm relative to placebo, irrespective of the HRT administration route (p = 0.055).

also in 11,409 other papers

a decreasing trendno p-value reported
an increasing trendno p-value reported
HDL-C showed an increasing trend in fenretinide users, versus a decreasing trend in the placebo group.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.